Tamar Thompson, VP of government affairs and policy at Alexion Pharmaceuticals, speaks with Marc Iskowitz about how the biotech company, which recently appointed its first chief diversity officer, has evolved on the D&I front and how she personally became involved in spearheading efforts to boost ethnic and gender equity in its workforce and clinical trials.